Severe asthma – identifying people at risk and improving access to treatment with biologics
No Thumbnail Available
Authors
Prigmore, Samantha
Issue Date
2024-12
Type
Article
Language
en
Keywords
Alternative Title
Abstract
Severe asthma is a complex chronic disease underpinned by several phenotypes and various comorbidities and risk factors. It affects a relatively small number of people but represents a heavy burden for individuals and the healthcare system. Recently, biologics have started to be used to treat severe asthma and have the potential to transform patients’ lives by reducing symptoms, exacerbations and reliance on oral corticosteroids. This article explains how to identify patients with poorly controlled asthma and describes the role of specialist asthma centres and severe asthma multidisciplinary teams in England. The authors also describe how a project in south west England made it possible to increase eligible patients’ access to treatment with biologics, through collaborative working between the South West Severe Asthma Network, acute trusts and severe asthma centres.
Description
Citation
Prigmore, S. (2024) 'Severe asthma – identifying people at risk and improving access to treatment with biologics', Primary Health Care Available At: 10.7748/phc.2024.e1844
Publisher
RCNi
License
Journal
Volume
Issue
PubMed ID
ISSN
0264-5033